Managing Director of Portfolio Strategies Craig Giventer, CFA®, recently discussed Johnson & Johnson (JNJ) as one of the leading dividend stocks to consider holding with U.S. News & World Report. “The company’s strong position in both pharmaceuticals and med tech allows the company to generate attractive rates of revenues, earnings and free cash flow growth,” he said.

Read the full story here: https://money.usnews.com/investing/articles/dividend-kings-to-buy-and-hold.

CAR20241007CGGYL